Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Cell Death Biomarkers and Obstructive Sleep Apnea: Implications in the Acute Coronary Syndrome.

Bauça JM, Yañez A, Fueyo L, de la Peña M, Pierola J, Sánchez-de-la-Torre A, Mediano O, Cabriada-Nuño V, Masdeu MJ, Teran-Santos J, Duran-Cantolla J, Masa JF, Abad J, Sanchez-de-la-Torre M, Barbé F, Barceló A; Spanish Sleep Network..

Sleep. 2017 May 1;40(5). doi: 10.1093/sleep/zsx049.

PMID:
28419383
2.

Response.

Alonso-Fernández A, de la Peña M, Carrera M, García Suquia A, Casitas R, García-Río F, Martinez-Ceron E, Pierola J, Barceló A, Soriano JB, Fernández-Capitán C.

Chest. 2017 Feb;151(2):515-516. doi: 10.1016/j.chest.2016.11.031. No abstract available.

PMID:
28183493
3.

Gut epithelial barrier markers in patients with obstructive sleep apnea.

Barceló A, Esquinas C, Robles J, Piérola J, De la Peña M, Aguilar I, Morell-Garcia D, Alonso A, Toledo N, Sánchez-de la Torre M, Barbé F.

Sleep Med. 2016 Oct;26:12-15. doi: 10.1016/j.sleep.2016.01.019. Epub 2016 Sep 28.

PMID:
28007354
4.

OSA Is a Risk Factor for Recurrent VTE.

Alonso-Fernández A, Suquia AG, de la Peña M, Casitas R, Pierola J, Barceló A, Soriano JB, Fernández-Capitán C, Martinez-Ceron E, Carrera M, García-Río F.

Chest. 2016 Dec;150(6):1291-1301. doi: 10.1016/j.chest.2016.07.011. Epub 2016 Jul 21.

PMID:
27452769
5.

Impact of Obstructive Sleep Apnea on the Levels of Placental Growth Factor (PlGF) and Their Value for Predicting Short-Term Adverse Outcomes in Patients with Acute Coronary Syndrome.

Barcelo A, Bauça JM, Yañez A, Fueyo L, Gomez C, de la Peña M, Pierola J, Rodriguez A, Sanchez-de-la-Torre M, Abad J, Mediano O, Amilibia J, Masdeu MJ, Teran J, Montserrat JM, Mayos M, Sanchez-de-la-Torre A, Barbé F; Spanish Sleep Group..

PLoS One. 2016 Mar 1;11(3):e0147686. doi: 10.1371/journal.pone.0147686. eCollection 2016.

6.

High D-dimer levels after stopping anticoagulants in pulmonary embolism with sleep apnoea.

García Suquia A, Alonso-Fernández A, de la Peña M, Romero D, Piérola J, Carrera M, Barceló A, Soriano JB, Arque M, Fernández-Capitán C, Lorenzo A, García-Río F.

Eur Respir J. 2015 Dec;46(6):1691-700. doi: 10.1183/13993003.02041-2014. Epub 2015 Jul 23.

PMID:
26206870
7.

Probe-based confocal laser endomicroscopy imaging of endobronchial hamartomas.

Shafiek H, Gómez C, Pierola J, Sauleda J, Cosío BG.

Respiration. 2014;88(6):484-6. doi: 10.1159/000368085. Epub 2014 Nov 14.

PMID:
25401423
8.

Efficacy of home single-channel nasal pressure for recommending continuous positive airway pressure treatment in sleep apnea.

Masa JF, Duran-Cantolla J, Capote F, Cabello M, Abad J, Garcia-Rio F, Ferrer A, Fortuna AM, Gonzalez-Mangado N, de la Peña M, Aizpuru F, Barbe F, Montserrat JM; Spanish Sleep Network..

Sleep. 2015 Jan 1;38(1):13-21. doi: 10.5665/sleep.4316.

9.

Effectiveness of home single-channel nasal pressure for sleep apnea diagnosis.

Masa JF, Duran-Cantolla J, Capote F, Cabello M, Abad J, Garcia-Rio F, Ferrer A, Mayos M, Gonzalez-Mangado N, de la Peña M, Aizpuru F, Barbe F, Montserrat JM; Spanish Sleep Network., Larrateguy LD, de Castro JR, Garcia-Ledesma E, Utrabo I, Corral J, Martinez-Null C, Egea C, Cancelo L, García-Díaz E, Carmona-Bernal C, Sánchez-Armengol A, Fortuna AM, Miralda RM, Troncoso MF, Monica G, Martinez-Martinez M, Cantalejo O, Piérola J, Vigil L, Embid C, Del Mar Centelles M, Prieto TR, Rojo B, Vanesa L.

Sleep. 2014 Dec 1;37(12):1953-61. doi: 10.5665/sleep.4248.

10.

Impact of obstructive sleep apnea on the 24-h metabolic hormone profile.

Sánchez-de-la-Torre M, Barceló A, Piérola J, de la Peña M, Valls J, Barbé F.

Sleep Med. 2014 Jun;15(6):625-30. doi: 10.1016/j.sleep.2014.03.007. Epub 2014 Apr 15.

PMID:
24856648
11.

Effect of CPAP treatment on plasma high sensitivity troponin levels in patients with obstructive sleep apnea.

Barceló A, Esquinas C, Bauçà JM, Piérola J, de la Peña M, Arqué M, Sánchez-de-la-Torre M, Alonso-Fernández A, Barbé F.

Respir Med. 2014 Jul;108(7):1060-3. doi: 10.1016/j.rmed.2014.04.005. Epub 2014 Apr 23.

12.

Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment.

Barceló A, Piérola J, Esquinas C, de la Peña M, Arqué M, Alonso-Fernández A, Bauçà JM, Robles J, Barceló B, Barbé F.

PLoS One. 2014 Jan 20;9(1):e84362. doi: 10.1371/journal.pone.0084362. eCollection 2014.

13.

Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial.

Martínez-García MA, Capote F, Campos-Rodríguez F, Lloberes P, Díaz de Atauri MJ, Somoza M, Masa JF, González M, Sacristán L, Barbé F, Durán-Cantolla J, Aizpuru F, Mañas E, Barreiro B, Mosteiro M, Cebrián JJ, de la Peña M, García-Río F, Maimó A, Zapater J, Hernández C, Grau SanMarti N, Montserrat JM; Spanish Sleep Network..

JAMA. 2013 Dec 11;310(22):2407-15. doi: 10.1001/jama.2013.281250.

PMID:
24327037
14.

Association between obstructive sleep apnea and pulmonary embolism.

Alonso-Fernández A, de la Peña M, Romero D, Piérola J, Carrera M, Barceló A, Soriano JB, García Suquia A, Fernández-Capitán C, Lorenzo A, García-Río F.

Mayo Clin Proc. 2013 Jun;88(6):579-87. doi: 10.1016/j.mayocp.2013.02.005. Epub 2013 Apr 8.

PMID:
23578813
15.

Vitamin D status and parathyroid hormone levels in patients with obstructive sleep apnea.

Barceló A, Esquinas C, Piérola J, De la Peña M, Sánchez-de-la-Torre M, Montserrat JM, Marín JM, Duran J, Arqué M, Bauça JM, Barbé F.

Respiration. 2013;86(4):295-301. doi: 10.1159/000342748. Epub 2012 Nov 15.

PMID:
23154407
16.

Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea.

Barceló A, Piérola J, Esquinas C, de la Peña M, Arqué M, la Torre MS, Alonso-Fernandez A, Barbé F.

Eur Respir J. 2012 Oct;40(4):1046-8. No abstract available.

17.

Double incontinence in a cohort of nulliparous pregnant women.

Espuña-Pons M, Solans-Domènech M, Sánchez E; Pelvic Floor Research Group (Grup de Recerca del Sòl Pelvià, GRESP)..

Neurourol Urodyn. 2012 Nov;31(8):1236-41. doi: 10.1002/nau.22249. Epub 2012 Apr 24.

PMID:
22532390
18.

The influence of obesity and obstructive sleep apnea on metabolic hormones.

Sánchez-de-la-Torre M, Mediano O, Barceló A, Piérola J, de la Peña M, Esquinas C, Miro A, Durán-Cantolla J, Agustí AG, Capote F, Marin JM, Montserrat JM, García-Río F, Barbé F.

Sleep Breath. 2012 Sep;16(3):649-56. doi: 10.1007/s11325-011-0552-7. Epub 2011 Sep 13.

PMID:
21912907
19.

Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea.

Sánchez-de-la-Torre M, Barceló A, Piérola J, Esquinas C, de la Peña M, Durán-Cantolla J, Capote F, Masa JF, Marin JM, Vilá M, Cao G, Martinez M, de Lecea L, Gozal D, Montserrat JM, Barbé F.

Respir Med. 2011 Dec;105(12):1954-60. doi: 10.1016/j.rmed.2011.08.014. Epub 2011 Sep 1.

20.

NADPH oxidase p22phox polymorphisms and oxidative stress in patients with obstructive sleep apnoea.

Piérola J, Alemany A, Yañez A, de-la-Peña M, Sánchez-de-la-Torre M, Esquinas C, Pérez-Gutierrez C, Burguera B, Barbé F, Barceló A.

Respir Med. 2011 Nov;105(11):1748-54. doi: 10.1016/j.rmed.2011.08.006. Epub 2011 Aug 27.

Supplemental Content

Loading ...
Support Center